These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29548017)

  • 1. Coping Strategies Mediate the Effect of Stressful Life Events on Schizotypal Traits and Psychotic Symptoms in 22q11.2 Deletion Syndrome.
    Armando M; Sandini C; Chambaz M; Schaer M; Schneider M; Eliez S
    Schizophr Bull; 2018 Oct; 44(suppl_2):S525-S535. PubMed ID: 29548017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
    Antshel KM; Fremont W; Ramanathan S; Kates WR
    Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizotypal traits in adolescents with 22q11.2 deletion syndrome: validity, reliability and risk for psychosis.
    Fonseca-Pedrero E; Debbané M; Schneider M; Badoud D; Eliez S
    Psychol Med; 2016 Apr; 46(5):1005-13. PubMed ID: 26670707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring associations between diurnal cortisol, stress, coping and psychopathology in adolescents and young adults with 22q11.2 deletion syndrome.
    Ilen L; Feller C; Eliez S; Micol E; Delavari F; Sandi C; Zanoletti O; Schneider M
    Compr Psychoneuroendocrinol; 2022 Feb; 9():100103. PubMed ID: 35755923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome.
    Montojo CA; Ibrahim A; Karlsgodt KH; Chow C; Hilton AE; Jonas RK; Vesagas TK; Bearden CE
    Neuroimage Clin; 2014; 4():392-402. PubMed ID: 24567911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-Scale Brain Network Dynamics Provide a Measure of Psychosis and Anxiety in 22q11.2 Deletion Syndrome.
    Zöller D; Sandini C; Karahanoğlu FI; Padula MC; Schaer M; Eliez S; Van De Ville D
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Oct; 4(10):881-892. PubMed ID: 31171499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary dysmaturation affects psychopathology and neurodevelopment in 22q11.2 Deletion Syndrome.
    Sandini C; Chambaz M; Schneider M; Armando M; Zöller D; Schaer M; Sandi C; Van De Ville D; Eliez S
    Psychoneuroendocrinology; 2020 Mar; 113():104540. PubMed ID: 31958652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower cortisol levels and attenuated cortisol reactivity to daily-life stressors in adults with 22q11.2 deletion syndrome.
    van Duin EDA; Vaessen T; Kasanova Z; Viechtbauer W; Reininghaus U; Saalbrink P; Vingerhoets C; Hernaus D; Booij J; Swillen A; Vorstman J; van Amelsvoort T; Myin-Germeys I
    Psychoneuroendocrinology; 2019 Aug; 106():85-94. PubMed ID: 30959234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping Subcortical Brain Alterations in 22q11.2 Deletion Syndrome: Effects of Deletion Size and Convergence With Idiopathic Neuropsychiatric Illness.
    Ching CRK; Gutman BA; Sun D; Villalon Reina J; Ragothaman A; Isaev D; Zavaliangos-Petropulu A; Lin A; Jonas RK; Kushan L; Pacheco-Hansen L; Vajdi A; Forsyth JK; Jalbrzikowski M; Bakker G; van Amelsvoort T; Antshel KM; Fremont W; Kates WR; Campbell LE; McCabe KL; Craig MC; Daly E; Gudbrandsen M; Murphy CM; Murphy DG; Murphy KC; Fiksinski A; Koops S; Vorstman J; Crowley TB; Emanuel BS; Gur RE; McDonald-McGinn DM; Roalf DR; Ruparel K; Schmitt JE; Zackai EH; Durdle CA; Goodrich-Hunsaker NJ; Simon TJ; Bassett AS; Butcher NJ; Chow EWC; Vila-Rodriguez F; Cunningham A; Doherty J; Linden DE; Moss H; Owen MJ; van den Bree M; Crossley NA; Repetto GM; Thompson PM; Bearden CE
    Am J Psychiatry; 2020 Jul; 177(7):589-600. PubMed ID: 32046535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive psychotic symptoms are associated with divergent developmental trajectories of hippocampal volume during late adolescence in patients with 22q11DS.
    Mancini V; Sandini C; Padula MC; Zöller D; Schneider M; Schaer M; Eliez S
    Mol Psychiatry; 2020 Nov; 25(11):2844-2859. PubMed ID: 31164700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal perspectives on the psychosis spectrum in 22q11.2 deletion syndrome.
    Tang SX; Gur RE
    Am J Med Genet A; 2018 Oct; 176(10):2192-2202. PubMed ID: 29048724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
    Vorstman JA; Breetvelt EJ; Duijff SN; Eliez S; Schneider M; Jalbrzikowski M; Armando M; Vicari S; Shashi V; Hooper SR; Chow EW; Fung WL; Butcher NJ; Young DA; McDonald-McGinn DM; Vogels A; van Amelsvoort T; Gothelf D; Weinberger R; Weizman A; Klaassen PW; Koops S; Kates WR; Antshel KM; Simon TJ; Ousley OY; Swillen A; Gur RE; Bearden CE; Kahn RS; Bassett AS;
    JAMA Psychiatry; 2015 Apr; 72(4):377-85. PubMed ID: 25715178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, course and psychosis-predictive value of negative symptoms in 22q11.2 deletion syndrome.
    Schneider M; Armando M; Schultze-Lutter F; Pontillo M; Vicari S; Debbané M; Eliez S
    Schizophr Res; 2019 Apr; 206():386-393. PubMed ID: 30414720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter abnormalities in 22q11.2 deletion syndrome patients showing cognitive decline.
    Nuninga JO; Bohlken MM; Koops S; Fiksinski AM; Mandl RCW; Breetvelt EJ; Duijff SN; Kahn RS; Sommer IEC; Vorstman JAS
    Psychol Med; 2018 Jul; 48(10):1655-1663. PubMed ID: 29143717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic Connectivity Network-Based Classification and Detection of Psychotic Symptoms in Youth With 22q11.2 Deletions.
    Schreiner M; Forsyth JK; Karlsgodt KH; Anderson AE; Hirsh N; Kushan L; Uddin LQ; Mattiacio L; Coman IL; Kates WR; Bearden CE
    Cereb Cortex; 2017 Jun; 27(6):3294-3306. PubMed ID: 28383675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural substrates of psychosis revealed by altered dependencies between brain activity and white-matter architecture in individuals with 22q11 deletion syndrome.
    Bortolin K; Delavari F; Preti MG; Sandini C; Mancini V; Mullier E; Van De Ville D; Eliez S
    Neuroimage Clin; 2022; 35():103075. PubMed ID: 35717884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical Morphology Differences in Subjects at Increased Vulnerability for Developing a Psychotic Disorder: A Comparison between Subjects with Ultra-High Risk and 22q11.2 Deletion Syndrome.
    Bakker G; Caan MW; Vingerhoets WA; da Silva-Alves F; de Koning M; Boot E; Nieman DH; de Haan L; Bloemen OJ; Booij J; van Amelsvoort TA
    PLoS One; 2016; 11(11):e0159928. PubMed ID: 27828960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotic symptoms influence the development of anterior cingulate BOLD variability in 22q11.2 deletion syndrome.
    Zöller D; Padula MC; Sandini C; Schneider M; Scariati E; Van De Ville D; Schaer M; Eliez S
    Schizophr Res; 2018 Mar; 193():319-328. PubMed ID: 28803847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric disorders in 22q11.2 deletion syndrome are prevalent but undertreated.
    Tang SX; Yi JJ; Calkins ME; Whinna DA; Kohler CG; Souders MC; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Psychol Med; 2014 Apr; 44(6):1267-77. PubMed ID: 24016317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.